Acción HEALTH NIGHTINGALE HEALTH OYJ
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Nightingale Health Oyj

Acciones

HEALTH

FI4000490875

Mercado cerrado - Nasdaq Helsinki
Otros sitios de cotización
 17:29:50 23/05/2024 		Varia. Cinco días. Varia. 1 de enero.
1,75 EUR +0,57 % Gráfico intradía de Nightingale Health Oyj +9,38 % +56,81 %
16/04 Nightingale Health establecerá un laboratorio en Estados Unidos CI
16/04 Nightingale Health y el Instituto Englander de Medicina de Precisión de Weill Cornell Medicine firman una carta de intenciones en la que las partes acuerdan colaborar en la adopción de la tecnología patentada de Nightingale Health en la atención sanitaria y la investigación médica en Estados Unidos CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Nightingale Health's Board of Directors extended the subscription period of employee option rights
Nightingale Health launches new website aligned with the B2B and B2G strategy
Inside information: Nightingale Health achieves one of its business targets for this financial year by winning contracts in medical research with a total contract value of at least EUR 3.2 million
Finland’s Nightingale Health Plots US Expansion
Nightingale Health to establish a laboratory in the United States with Weill Cornell Medicine as the first customer
Nightingale Health to Establish A Laboratory in the United States
Nightingale Health and the Englander Institute for Precision Medicine At Weill Cornell Medicine Sign A Letter of Intent in Which the Parties Agree to Collaborate on the Adoption of Nightingale Health's Proprietary Technology in Healthcare and Medical Research in the United States
Nightingale Health Secures Blood Analysis Contract with Kaiser Foundation
Supplement to the release: Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.
Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.
Nightingale Health Enters into Agreement to Analyze 50,000 Blood Samples with Kaiser Foundation Health Plan, Inc
Nightingale Health Closes Purchase of Japan's Welltus
Nightingale Health has completed the acquisition of Welltus Inc
Nightingale Health Oyj completed the acquisition of Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.
Conversion of Nightingale Health Plc's EMP shares to Series B shares
Nightingale Health's technology used to analyze Uganda's General Population Cohort (GPC)
Nightingale Health plc Enters into an Agreement in Which It Will Analyze Blood Samples from Uganda's General Population Cohort
Finland-based Nightingale Health to Buy Japan's Welltus
Supplement to the release: Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc
Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción HEALTH
  4. Noticias Nightingale Health Oyj
  5. Otros idiomas
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA